A Bosly

847 total citations
18 papers, 684 citations indexed

About

A Bosly is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, A Bosly has authored 18 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 9 papers in Pathology and Forensic Medicine and 6 papers in Hematology. Recurrent topics in A Bosly's work include Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Viral-associated cancers and disorders (3 papers). A Bosly is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Viral-associated cancers and disorders (3 papers). A Bosly collaborates with scholars based in France and Belgium. A Bosly's co-authors include Bertrand Coiffier, Corinne Haïoun, Christian Gisselbrecht, Pauline Brice, Y Bastion, Hervé Tilly, H Tilly, Éric Lepage, F Reyes and André Delannoy and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

A Bosly

18 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Bosly France 10 494 322 314 164 133 18 684
John Apostolidis Greece 13 586 1.2× 473 1.5× 214 0.7× 223 1.4× 148 1.1× 34 810
J Pierson United States 12 519 1.1× 340 1.1× 242 0.8× 125 0.8× 141 1.1× 13 651
R Pearce United Kingdom 7 373 0.8× 312 1.0× 152 0.5× 243 1.5× 93 0.7× 9 576
JM Vose United States 10 529 1.1× 461 1.4× 199 0.6× 264 1.6× 128 1.0× 13 748
R E Hutchison United States 9 468 0.9× 244 0.8× 172 0.5× 59 0.4× 169 1.3× 14 598
R. Zschaber Germany 9 691 1.4× 572 1.8× 198 0.6× 160 1.0× 93 0.7× 17 901
K Pesek United States 8 495 1.0× 277 0.9× 393 1.3× 264 1.6× 166 1.2× 8 711
K Blake United States 7 501 1.0× 371 1.2× 267 0.9× 307 1.9× 192 1.4× 10 853
PA Bryon France 9 531 1.1× 340 1.1× 356 1.1× 86 0.5× 80 0.6× 18 669
P. J. Bierman United States 11 340 0.7× 248 0.8× 135 0.4× 255 1.6× 74 0.6× 21 592

Countries citing papers authored by A Bosly

Since Specialization
Citations

This map shows the geographic impact of A Bosly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Bosly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Bosly more than expected).

Fields of papers citing papers by A Bosly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Bosly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Bosly. The network helps show where A Bosly may publish in the future.

Co-authorship network of co-authors of A Bosly

This figure shows the co-authorship network connecting the top 25 collaborators of A Bosly. A scholar is included among the top collaborators of A Bosly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Bosly. A Bosly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mounier, Nicolas, Michele Spina, Jean Gabarre, et al.. (2005). Treatment of human immunodeficiency virus-related lymphoma with risk-adapted intensive chemotherapy: Final analysis of the NHL-HIV 93 trial. Journal of Clinical Oncology. 23(16_suppl). 6524–6524. 1 indexed citations
2.
Sonet, Anne, Ivan Théate, Philippe Mineur, et al.. (2004). CLINICAL AND PATHOLOGICAL FEATURES OF 14 NON-HODGKINʼS LYMPHOMAS ASSOCIATED WITH COELIAC DISEASE. Acta Clinica Belgica. 59(3). 143–151. 3 indexed citations
3.
Mounier, Nicolas, Christian Gisselbrecht, Josette Brière, et al.. (2003). Prognostic factors for aggressive lymphoma patients treated with front-line autotransplantation after complete remission: A cohort study on 330 patients. Blood. 102(11). 246. 1 indexed citations
4.
Bosly, A & C Gisselbrecht. (2001). [Therapy intensification with autologous transplantation in non-Hodgkin's lymphomas].. PubMed. 88(9). 877–87. 2 indexed citations
5.
Ganem, G., Éric Lepage, Isabelle Gaillard, et al.. (2001). Three chop followed by radiotherapy versus a more intensive chemotherapy alone in low risk localized aggressive non Hodgkin’s lymphoma (NHL): Preliminary results of the Gela-LNH 93-1 study. International Journal of Radiation Oncology*Biology*Physics. 51(3). 67–67. 1 indexed citations
6.
Haïoun, Corinne, Éric Lepage, Christian Gisselbrecht, et al.. (1997). Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.. Journal of Clinical Oncology. 15(3). 1131–1137. 226 indexed citations
7.
Solal-Céligny, P., Pauline Brice, Nicole Brousse, et al.. (1996). Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.. Journal of Clinical Oncology. 14(2). 514–519. 127 indexed citations
8.
Kluin‐Nelemans, Hanneke C., André Delannoy, Marc Boogaerts, et al.. (1995). CML treated by low dose interferon alfa-2B vs hydroxyurea alone: interim report of a multicenter randomized trial. Blood. 86. 1 indexed citations
9.
Delannoy, André, Philippe Martiat, Jean‐Luc Gala, et al.. (1995). 2-Chlorodeoxyadenosine (CdA) for patients with previously untreated chronic lymphocytic leukemia (CLL).. PubMed. 9(7). 1130–5. 41 indexed citations
10.
Gisselbrecht, C, D Maraninchi, JL Pico, et al.. (1994). Interleukin-2 treatment in lymphoma: a phase II multicenter study [see comments]. Blood. 83(8). 2081–2085. 3 indexed citations
11.
Delannoy, André, et al.. (1994). 2-Chlorodeoxyadenosine therapy in Waldenstrom's macroglobulinaemia.. PubMed. 36(4). 317–20. 27 indexed citations
12.
Filleul, Bertrand, A. Zenebergh, Sabine Van daele, et al.. (1994). A single course of 2-chloro-deoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission.. PubMed. 8(7). 1153–6. 47 indexed citations
13.
Gisselbrecht, C, D Maraninchi, JL Pico, et al.. (1994). Interleukin-2 treatment in lymphoma: a phase II multicenter study [see comments]. Blood. 83(8). 2081–2085. 50 indexed citations
14.
Gisselbrecht, Christian, A Bosly, Éric Lepage, et al.. (1993). Autologous hematopoietic stem cell transplantation in intermediate and high grade Non-Hodgkin's lymphoma: A review. Annals of Oncology. 4. S7–S13. 18 indexed citations
15.
Bosly, A, Bertrand Coiffier, Christian Gisselbrecht, et al.. (1992). Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.. Journal of Clinical Oncology. 10(10). 1615–1623. 79 indexed citations
16.
Doyen, Chantal, André Delannoy, Guy Cornu, et al.. (1991). Allogeneic or autologous bone marrow transplantation for acute non-lymphocytic leukemia in first remission.. PubMed. 7(4). 303–9. 19 indexed citations
17.
Delannoy, André, A Ferrant, A Bosly, et al.. (1990). Acute lymphoblastic leukemia in the elderly. European Journal Of Haematology. 45(2). 90–93. 37 indexed citations
18.
Symann, Michel, Yves Humblet, & A Bosly. (1989). [Clinical and biological aspects of intensive chemotherapy with autologous bone marrow grafts in small-cell bronchial cancer].. PubMed. 144(3-4). 213–21; discussion 222. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026